JPRN-UMIN000008274已完成未知
Comparison of the effects of sitagliptin and mitiglinide/voglibose fixed-dose combination tablets on glucose metabolism in patients with uncontrolled type-2 diabetes mellitus. - Comparison of the effects of sitagliptin and mitiglinide/voglibose fixed-dose combination tablets on glucose metabolism
niversity of Occupational and Environmental Health, Japan0 个研究点目标入组 5 人开始时间: 2012年6月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
Increasing the dose of STG to 100 mg/day reduces blood glucose levels from midnight to early morning in patients with postprandial hyperglycemia who have HbA1c values of approximately 7%, FPG levels of approximately 120 mg/dL, and postprandial glucose levels >200 mg/dL. In addition, switching to MIT/VOG improves fluctuations in blood glucose levels and postprandial hyperglycemia.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients treated with a sulfonylurea (SU), alfa-glycosidase inhibitor (alfa-GI) or insulin secretagogue (glinide). 2) Patients with diabetic ketoacidosis, diabetic coma/precoma or type-1 diabetes mellitus. 3) Patients with severe infection or serious trauma, or those operated recently or scheduled for surgery. 4) Patients with moderate or severer renal disorder (creatinine level 1.5 mg/dL (men) or 1.3 mg/dL (women)). 5) Patients with liver disorder (AST or ALT level 3 times the normal upper limit). 6) Women who are pregnant or suspected of being pregnant. 7) Women who are breastfeeding. 8) Patients with a history of hypersensitivity to an ingredient of the study drugs. 9) Other patients judged to be ineligible by the investigator.
研究者
相似试验
已完成
不适用
Effects of sitagliptin on daily glucose fluctuation in Japanese type 2 diabetic outpatients inadequately controlled with insulin therapyJPRN-UMIN000012735Aichi Medical University Division of Diabetes, Department of Internal Medicine, Diabetes Center30
已完成
4 期
Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and SulfonylureaType 2 DiabetesNCT01195090Sung-Chen Liu120
Unknown
2 期
Effect of Sitagliptin in Impaired Glucose ToleranceImpaired Glucose ToleranceNCT00961363National Taiwan University Hospital60
撤回
不适用
Sitagliptin in Type I Diabetic PatientsDiabetes Type INCT01741103University at Buffalo
已完成
不适用
Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid TherapyPre-diabetesImpaired Fasting GlucoseImpaired Glucose ToleranceNCT01488279University of Vermont10